Zobrazeno 1 - 2
of 2
pro vyhledávání: '"RL Curry-Edwards"'
Autor:
Rebecca J. Nagy, Amir Ali Talasaz, Alfred Rademaker, Sarika Jain, William J. Gradishar, Lisa Flaum, RL Curry-Edwards, Giovanna Rossi, Cesar A. Santa-Maria, R Lima Barros Costa, Leonidas C. Platanias, Vittorina Zagonel, Massimo Cristofanilli, Francis J. Giles
Publikováno v:
Cancer Research. 77:P1-05
Background: Estrogen receptor (ER)-α is expressed in about 70% of breast cancers and drugs that target the receptor function, selective estrogen receptor modulators (SERM) and aromatase inhibitors (AIs) represent the standard of care for patients (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c14662b6c1171a922a17164f9b6ebdfb
https://doi.org/10.1158/1538-7445.sabcs16-p1-05-06
https://doi.org/10.1158/1538-7445.sabcs16-p1-05-06
Autor:
Alfred Rademaker, Lisa Flaum, RL Curry-Edwards, R Lima Barros Costa, Rebecca J. Nagy, Vittorina Zagonel, Massimo Cristofanilli, Francis J. Giles, Laura Austin, Sarika Jain, Cesar A. Santa-Maria, Amir Ali Talasaz, Leonidas C. Platanias, Giovanna Rossi, William J. Gradishar
Publikováno v:
Cancer Research. 77:PD1-02
Background: Molecular diagnostic, in particular next-generation sequencing (NGS) technologies, improved the detection of actionable mutations (muts) in MBC at baseline and recurrence. We evaluated the ability of ctDNA to detect molecular abnormalitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300a1cd8d4bbf3a6496f70462b68bb19
https://doi.org/10.1158/1538-7445.sabcs16-pd1-02
https://doi.org/10.1158/1538-7445.sabcs16-pd1-02